Temozolomide (Sandoz Inc.)
Welcome to the PulseAid listing for the Temozolomide drug offered from Sandoz Inc.. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sandoz Inc. |
NON-PROPRIETARY NAME: | Temozolomide |
SUBSTANCE NAME: | TEMOZOLOMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 2013-08-12 |
END MARKETING DATE: | 0000-00-00 |
Temozolomide HUMAN PRESCRIPTION DRUG Details:
Item Description | Temozolomide from Sandoz Inc. |
LABELER NAME: | Sandoz Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/1) |
START MARKETING DATE: | 2013-08-12 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0781-2691_a750842d-b4f8-4569-9b94-e0520a4d21af |
PRODUCT NDC: | 0781-2691 |
APPLICATION NUMBER: | NDA021029 |
Other TEMOZOLOMIDE Pharmaceutical Manufacturers / Labelers: